Loading clinical trials...
Loading clinical trials...
Hereditary Haemorrhagic Telangiectasia (HHT) is a condition in which sufferers have abnormal blood vessels which makes them more likely to bleed than other people, particularly in the lungs, which res...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Imperial College London
NCT07414446 · Hereditary Haemorrhagic Telangiectasia, PFO - Patent Foramen Ovale, and more
NCT03841422 · Hereditary Haemorrhagic Telangiectasia
NCT07474428 · Hereditary Haemorrhagic Telangiectasia (HHT)
NCT03981562 · Hereditary Haemorrhagic Telangiectasia
NCT03940014 · Hereditary Haemorrhagic Telangiectasia, Pulmonary Arteriovenous Malformation, and more
HammersmithHospital, Imperial College Healthcare NHS Trust
London
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions